1982
DOI: 10.1111/j.1365-2125.1982.tb01909.x
|View full text |Cite
|
Sign up to set email alerts
|

Pindolol‐a beta‐adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.

Abstract: 1 Pindolol is a beta‐adrenoceptor antagonist equally effective on beta 1‐ and beta 2‐adrenoceptors which has a relatively long duration of action. It is practically completely absorbed and, unlike most other beta‐adrenoceptor blockers, is only metabolized to a small extent during the first passage through the liver. 2 Pindolol possesses partial agonist activity (intrinsic sympathomimetic activity, ISA). This means that apart from blocking beta‐adrenoceptors it produces some stimulation. Pindolol therefore only… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
18
0

Year Published

1984
1984
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 53 publications
(18 citation statements)
references
References 63 publications
0
18
0
Order By: Relevance
“…The aim of this study was to determine the effects of three different ,B-adrenoceptor drugs: epanolol (1l-selective with PAA (Pringle et al, 1986)), atenolol (31-selective with no PAA) and pindolol (non-selective with PAA) on heart rate and physiological tremor in diabetics with autonomic neuropathy. Their selectivity or otherwise has been established in man (Harry, 1977;Aellig, 1982;Norris et al, 1984;Pringle et al, 1986). In animals, atenolol has been shown to have no PAA, while epanolol and pindolol do (Harry et al, 1974;Bilski et al, 1979;Smith et al, 1983).…”
Section: Introductionmentioning
confidence: 98%
“…The aim of this study was to determine the effects of three different ,B-adrenoceptor drugs: epanolol (1l-selective with PAA (Pringle et al, 1986)), atenolol (31-selective with no PAA) and pindolol (non-selective with PAA) on heart rate and physiological tremor in diabetics with autonomic neuropathy. Their selectivity or otherwise has been established in man (Harry, 1977;Aellig, 1982;Norris et al, 1984;Pringle et al, 1986). In animals, atenolol has been shown to have no PAA, while epanolol and pindolol do (Harry et al, 1974;Bilski et al, 1979;Smith et al, 1983).…”
Section: Introductionmentioning
confidence: 98%
“…This effect is inversely related to the background sympathetic activity [10,11]. Consequently, exercise at intensities producing an ele vated sympathetic activity reduces or eliminates the en hancement of cardiac function attributable to a sympatho mimetic effect [12], and other conditions or perturbations producing an elevated sympathetic activity also attenuate ISA effects [13].…”
Section: Discussionmentioning
confidence: 99%
“…cause any stimulation of these receptors (Aellig, 1982). Pindolol is also a non-specific /3-adrenoceptor antagonist, but with ISA, i.e.…”
Section: Introductionmentioning
confidence: 99%
“…it blocks fl-receptors but also acts as a partial agonist (Aellig, 1982). This partial agonist activity of pindolol is said to be about as high as the normal resting sympathetic activity, and consequently it has been shown to reduce only enhanced sympathetic tone, whereas fi-adrenoceptor antagonists without ISA reduce even normal sympathetic activity (Aellig, 1982).…”
Section: Introductionmentioning
confidence: 99%